We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$24.2B
AUM Growth
+$1.98B
Cap. Flow
+$650M
Cap. Flow %
2.69%
Top 10 Hldgs %
20.94%
Holding
1,937
New
668
Increased
334
Reduced
448
Closed
480

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$396M
2
META icon
Meta Platforms (Facebook)
META
+$342M
3
MSFT icon
Microsoft
MSFT
+$257M
4
ZM icon
Zoom
ZM
+$215M
5
ADBE icon
Adobe
ADBE
+$168M

Sector Composition

Rank Sector Weight
1 Healthcare 25.92%
2 Technology 19.33%
3 Communication Services 11.12%
4 Consumer Discretionary 10.85%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
1
Amazon
AMZN
$2.87T
$907M 3.75%
5,864,060
+2,495,760
+74% +$396M
MSFT icon
2
Microsoft
MSFT
$3.81T
$798M 3.3%
3,384,113
+1,107,236
+49% +$257M
AAPL icon
3
Apple
AAPL
$4.67T
$618M 2.56%
5,060,194
+373,855
+8% +$48M
META icon
4
Meta Platforms (Facebook)
META
$1.47T
$603M 2.49%
2,046,693
+1,270,014
+164% +$342M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.19T
$474M 1.96%
4,581,840
+257,360
+6% +$25.5M
ZTS icon
6
Zoetis
ZTS
$32B
$420M 1.74%
2,668,161
+143,515
+6% +$22.7M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$418M 1.73%
4,054,580
-243,640
-6% -$24M
TMO icon
8
Thermo Fisher Scientific
TMO
$230B
$332M 1.37%
727,520
-83,070
-10% -$39.6M
ELV icon
9
Elevance Health
ELV
$85.5B
$278M 1.15%
775,471
-72,377
-9% -$23.3M
INTC icon
10
Intel
INTC
$473B
$218M 0.9%
3,406,674
+2,206,674
+184% +$132M
UNH icon
11
UnitedHealth
UNH
$353B
$218M 0.9%
584,618
+374,606
+178% +$130M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$137B
$212M 0.88%
987,288
+272,560
+38% +$59.9M
DHR icon
13
Danaher
DHR
$152B
$205M 0.85%
1,029,673
-468,823
-31% -$95.2M
PYPL icon
14
PayPal
PYPL
$45.9B
$203M 0.84%
837,047
+200,201
+31% +$50.6M
BMY icon
15
Bristol-Myers Squibb
BMY
$136B
$196M 0.81%
3,097,335
-741,084
-19% -$46.1M
ZM icon
16
Zoom
ZM
$28.7B
$187M 0.77%
+583,140
New +$215M
BSX icon
17
Boston Scientific
BSX
$67.9B
$184M 0.76%
4,770,393
+180,286
+4% +$6.82M
ADBE icon
18
Adobe
ADBE
$116B
$174M 0.72%
365,028
+360,140
+7,368% +$168M
T icon
19
AT&T
T
$178B
$159M 0.66%
6,972,311
+4,642,254
+199% +$103M
LIN icon
20
Linde
LIN
$226B
$158M 0.65%
562,331
-71,120
-11% -$18.5M
V icon
21
Visa
V
$712B
$155M 0.64%
730,774
+610,788
+509% +$129M
CNC icon
22
Centene
CNC
$32B
$153M 0.63%
2,388,043
+1,401,374
+142% +$86.8M
IFF icon
23
International Flavors & Fragrances
IFF
$22.4B
$150M 0.62%
1,076,619
+927,834
+624% +$120M
GPN icon
24
Global Payments
GPN
$24.3B
$143M 0.59%
711,310
+6,100
+0.9% +$1.22M
INFO
25
DELISTED
IHS Markit Ltd. Common Shares
INFO
$143M 0.59%
1,474,732
-289,467
-16% -$26.5M

Similar funds

Marshall Wace North America's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace North America held 1,937 positions worth $24.2B, up 8.9% from $22.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America's Q1 2021 filing shows 668 new, 334 increased, 448 reduced and 480 closed positions. Its largest new stake was Zoom: 583,140 shares worth $187M. The largest sale was Home Depot, an estimated $235M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Marshall Wace North America's largest Q1 2021 buy was Zoom: 583,140 shares worth $187M.
  • Marshall Wace North America added most to Amazon in Q1 2021, an estimated $396M increase.
  • Marshall Wace North America's biggest Q1 2021 reduction was Home Depot, cutting an estimated $235M.
  • Marshall Wace North America fully exited Alexion Pharmaceuticals in Q1 2021, selling an estimated $100M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $24.2B portfolio in Q1 2021.
  • Marshall Wace North America opened 668 new positions and closed 480 in Q1 2021.
  • Marshall Wace North America's portfolio value rose 8.9% quarter-over-quarter to $24.2B.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.